Real world effectiveness of regorafenib in heavily pretreated patients with metastatic colorectal cancer.

被引：0
|
作者：
Danilova, Anastasia
Stroyakovsky, Daniil
Kanner, Dmitry
Chernikovksy, Ilya
Savelov, Nikita
Volkonsky, Mikhail
Demidova, Irina
机构：
[1] Moscow City Oncol Hosp 62, Krasnogorskiy Rayon, Russia
[2] Moscow City Oncol Hosp 62, Moscow, Russia
[3] Moscow City Oncol Hosp 62, Stepanovskoe, Russia
[4] SBIH Moscow City Oncol Hosp 62 DHM, Moscow, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
298-11050; 283-237-255-11316; 261-492-199; 3282-206-4957-326-5009-5024-5025; 3282-206-4957-326-5009-2386; 613-135-244-3829-325; 10; 4; 3; 2; 250; 7; 38092-28187; 38092-25821; 38092-18849; 1;
D O I：
10.1200/JCO.2024.42.3_suppl.141
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of regorafenib for pretreated metastatic colorectal cancer patients in the United States
    Seal, Brian S.
    Oezer-Stillman, Ipek
    Whalen, John
    Ambavane, Apoorva
    Yaldo, Avin
    Pawar, Vivek
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [2] Cost-effectiveness analysis of regorafenib for metastatic colorectal cancer.
    Goldstein, Daniel A.
    Ahmad, Bilal B.
    Chen, Qiushi
    Ayer, Turgay
    Howard, David H.
    Lipscomb, Joseph
    El-Rayes, Bassel F.
    Flowers, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [3] Real-world effectiveness of regorafenib in the treatment of patients with metastatic colorectal cancer: A retrospective, observational study
    Wang, Hailing
    Liu, Weiling
    Zhao, Yan
    Hu, Hongtao
    Zhang, Bin
    Yang, Shujun
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (05) : E291 - E299
  • [4] Colorectal Cancer Regorafenib in metastatic, pretreated Tumors
    Krome, Susanne
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (06): : 530 - 530
  • [5] Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study
    Pedersini, Rebecca
    Vassalli, Lucia
    Claps, Melanie
    Tulla, Antonella
    Rodella, Filippo
    Grisanti, Salvatore
    Amoroso, Vito
    Roca, Elisa
    Simoncini, Edda Lucia
    Berruti, Alfredo
    ONCOLOGY, 2018, 94 : 10 - 15
  • [6] Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan
    Yeh, Kun-Huei
    Yang, Tsai-Sheng
    Hsu, Tzu-Chi
    Chen, William Tzu-Liang
    Chen, Hong-Hwa
    Teng, Hao-Wei
    Lin, Bo-Wen
    Kuan, Feng-Che
    Chiang, Feng-Fan
    Duann, Chi-Wei
    Li, Ying-Shiuan
    Lin, Meng-Ting
    Fiala-Buskies, Sabine
    Ducreux, Michel
    Wang, Jaw-Yuan
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (11) : 2023 - 2031
  • [7] Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohort
    Metges, Jean-Philippe
    Genet, Dominique
    Tougeron, David
    Ligeza, Catherine
    Ducreux, Michel
    Borg, Christophe
    Guimbaud, Rosine
    Phelip, Jean-Marc
    Dourthe, Louis-Marie
    Kim, Stefano
    FUTURE ONCOLOGY, 2021, 17 (25) : 3343 - 3353
  • [8] Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: a multicenter retrospective study
    Zhao, Yannan
    Xie, Ning
    Li, Wei
    Chen, Wenyan
    Lv, Zheng
    Zheng, Yabing
    Sun, Tao
    Liu, Jieqiong
    Zhang, Jian
    Hu, Shihui
    Wang, Yajun
    Gong, Chengcheng
    Li, Yi
    Xie, Yizhao
    Ge, Rui
    Xu, Fei
    Wang, Biyun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [9] Factors associated with effectiveness of trifluridine/tipiracil versus regorafenib in patients with pretreated metastatic colorectal cancer (mCRC)
    Grell, Peter
    Borilova, Simona
    Schwanzerova, Renata
    Kukolikova, Sabina
    Dvorak, Josef
    Vocka, Michal
    John, Stanislav
    Buchler, Tomas
    Selingerova, Iveta
    Petruzelka, Lubos B.
    Vyzula, Rostislav
    Kiss, Igor
    Obermannova, Radka
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [10] Regorafenib plus tislelizumab for patients with metastatic colorectal cancer: A real-world study
    Gao, Xiang
    Chen, Xiaoping
    Zhao, Yutian
    Mao, Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345